Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2023-03-20 00:00:00 ET · period of report 2023-03-16 · accession 0001415889-23-005218 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $1.67 | +11.2K | 32.4K | +53% | +$18.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-16 | A | A | 11,228 | $1.67 | 32,385 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on March 16, 2023. |